Who invested in Spark Therapeutics?
Spark Therapeutics's investors include Wellington Management, Deerfield, Sofinnova Investments, T. Rowe Price and Brookside Capital, and 2 more on record.
United States · Series B startup
2 rounds we have observed, with the 7 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Spark Therapeutics and see its new rounds in your feed.Sign up free
Funding summaryUpdated 27 Oct 2026
$123Mraised across 2 rounds since 2013, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding recordSEC filing: $73M sold, first sale May 2014
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Spark Therapeutics's investors include Wellington Management, Deerfield, Sofinnova Investments, T. Rowe Price and Brookside Capital, and 2 more on record.
Spark Therapeutics has raised $123M across 2 rounds since 2013.
Spark Therapeutics's most recent round was a Series B of $73M in May 2014.
Its most recent round, $73M in May 2014, is also its largest on record.
Spark Therapeutics's first round on record, in Oct 2013, was backed by The Children's Hospital of Philadelphia.
Spark Therapeutics's latest named round is a Series B, in May 2014.
Spark Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.